CROTAMITON

CROTAMITON
(kroe-tam'i-tonn)
Eurax
Classifications: scabicide; antipruritic;
Therapeutic: scabicide; antipruritic
Prototype: Lindane
Pregnancy Category: C

Availability

10% cream, lotion

Action

By unknown mechanisms, drug eradicates Sarcoptes scabiei and effectively relieves itching.

Therapeutic Effect

Scabicidal and antipruritic agent.

Uses

Treatment of scabies and for symptomatic treatment of pruritus.

Contraindications

Application to acutely inflamed skin, raw or weeping surfaces, eyes, or mouth; history of previous sensitivity to crotamiton; pregnancy (category C).

Route & Dosage

Scabies
Adult/Child: Topical Apply a thin layer of cream from neck to toes; apply a second layer 24 h later. Bathe 48 h after last application to remove drug.

Administration

Topical

Shake container well before use of solution.
The skin must be thoroughly dry before applying medication.
If drug accidentally contacts eyes, thoroughly flush out medication with water.
Pruritus treatment: massage medication gently into affected areas until it is completely absorbed. Repeat as needed (usually effective for 6–10 h).
Store in tightly closed containers at 15°–30° C (59°–86° F). Do not freeze.

Adverse Effects (≥1%)

Skin: Skin irritation (particularly with prolonged use), rash, erythema, sensation of warmth, allergic sensitization.

Interactions

Drug: No clinically significant interactions established.

Nursing Implications

Assessment & Drug Effects

Monitor for and report significant skin irritation or allergic sensitization.

Patient & Family Education

Review package insert before treatment begins.
Discontinue medication and report to physician if irritation or sensitization develops.

Common adverse effects in italic, life-threatening effects underlined; generic names in bold; classifications in SMALL CAPS; Canadian drug name; Prototype drug

(45)